The resistance pattern of Staphylococci against beta-lactam group of antibiotics in Hyderabad city of Pakistan.

Shama Hashmani| Bushra Bano Patoli| Nimerta Kumari| Atif Ahmed Patoli| Shagufta Jabeen

Abstract
Objective: To estimate the frequency of antibiotic resistance among the Staphylococci against a set of beta (Î²) lactam group of antibiotics.
Methodology: A total of 156 cultures of Staphylococci were isolated from clinical specimens and based on the coagulase production were categorized into two groups as; Coagulase Positive Staphylococci (CoPS) and Coagulase Negative Staphylococci (CoNS). The antibiotic resistance was determined using Kirby Baur disc diffusion method.
Results: Out of 156 isolates 57.6% (n=90) isolates were from male patients while 42.4% (n=66) were from female patients. About 62.1 % (n=97) of the isolates were CoPS while 37.9 % (n=59) were CoNS. Among CoPS the highest percentage of resistance (97.9%) was observed against penicillin G whereas among the CoNS the highest resistance was observed against Cefixime (93.2%). The comparative analysis for their potential to resist various members of beta-lactam antibiotics between CoPS and CoNS suggested non-significant differences for majority of the antibiotics used in this study. Comparatively higher resistance against amoxicillin was seen for CoPS (92.7%) than CoNS (79.6%). The odd ratio (OR) and confidence interval (CI 95%) for amoxicillin resistance between CoPS vs CoNS was calculated to be: 3.28 ( 1.21 – 8.89), while the p-values were determined to be 0.015 using chi square test of independence applying 2x2 contingency table. These values suggest a significant association of amoxicillin resistance with CoPS.
Conclusion: In general, beta-lactam antibiotic resistance in Staphylococcal isolates is observed greater in Hyderabad as compared to the previously described resistance in other regions of Pakistan.

Key words: Staphylococcus aureus, Coagulase-Negative Staphylococci (CoNs), beta-lactam antibiotics.

ABOUT JOURNAL About Publisher Contact Us Editorial & Peer Review Process	POLICIES Privacy Policy Editorial Policy Author's Rights and Obligations Conflict of Interest Policy Plagiarism Policy Advertising Policy	STATEMENTS Terms of Use Author's Rights and Obligations Publication Ethics and Publication Malpractice Statement Protection of Research Participants (Statement On Human And Animal Rights) License Information

This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access. The articles in Rawal Medical Journal are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

Indexed in WHO Index Medicus IMEMR, Emromedex, Pakmedinet, ExtraMED, Scopus and Web of Science

How to cite this article

	Open Access and Peer-reviewed
Home Journal Issues Guide for Authors Editorial Board Aims & Scope About Journal News & Announcements